The rapid enrollment design for Phase I clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The rapid enrollment design for Phase I clinical trials

Published:2016-02-01 Issue:15 Volume:35 Page:2516-2524
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Ivanova Anastasia¹,Wang Yunfei²,Foster Matthew C.³

Affiliation:

1. Department of Biostatistics; University of North Carolina at Chapel Hill; Chapel Hill NC 27599-7420 U.S.A.

2. Departments of Pediatrics and Biostatistics; George Washington University and Children's National Medical Center; Washington DC 20010 U.S.A.

3. University of North Carolina; Lineberger Comprehensive Cancer Center, Chapel Hill; NC 27599 U.S.A.

Funder

National Institutes of Health

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.6886/fullpdf

Reference18 articles.

1. Sequential estimation of quantal response curves;Wetherill;Journal of the Royal Statistical Society B,1963

2. Continual reassessment method: a practical design for phase 1 clinical trials in cancer;O'Quigley;Biometrics,1990

3. Cancer phase I clinical trials: efficient dose escalation with overdose control;Babb;Statistics in Medicine,1998

4. Escalation with overdose control using time to toxicity for cancer phase I clinical trials;Tighiouart;PloS One,2014 Mar 24

5. Adaptive clinical trial designs for phase I cancer studies;Sverdlov;Statistics Surveys,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design;Statistics in Medicine;2024-07-29

2. Statistical Frameworks for Oncology Dose-Finding Designs with Late-Onset Toxicities: A Review;Statistical Science;2024-05-01

3. Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects;JCO Precision Oncology;2024-02

4. Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression;Statistics in Medicine;2022-10-19

5. A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations;Clinical Cancer Research;2022-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3